2-hydroxydibenzofuran
structure in first source
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Chen, Wu:
1 article
(01/2022)
|
| 2. | Chen, Xi:
1 article
(01/2022)
|
| 3. | Han, Yiqun:
1 article
(01/2022)
|
| 4. | Hu, Xinyan:
1 article
(01/2022)
|
| 5. | Li, Xiaoying:
1 article
(01/2022)
|
| 6. | Liu, Jinming:
1 article
(01/2022)
|
| 7. | Lu, Xinchen:
1 article
(01/2022)
|
| 8. | Luan, Mengxiao:
1 article
(01/2022)
|
| 9. | Qiu, Xinghua:
1 article
(01/2022)
|
| 10. | Wang, Teng:
1 article
(01/2022)
|
Related Diseases
| 1. | Chronic Obstructive Pulmonary Disease (COPD)
01/01/2022
- " Among the high-risk factors for COPD patients, the responses to UFPs, Acc, and 2-hydroxydibenzofuran were not robust in non-COPD participants. " 01/01/2022
- " In COPD patients, the associations of TNFα differences with exposure to ozone, Cd, UFPs, Acc, 2-hydroxydibenzofuran, temperature and RH parameters, and several elements in PM2.5 were significant in certain time-windows. "
|
| 2. | Dehydration (Water Stress)
|
|
Related Drugs and Biologics